EGF樣域蛋白7(EGFL7)多克隆抗體
Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7)
ZNEU1; MEGF7; Zneu1; Vascular endothelial statin; EGF Like Domain Containing 7; Epidermal growth factor-like protein 7; Multiple epidermal growth factor-like domains protein 7
- 編號PAL643Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPL643Mu01-EGF樣域蛋白7(EGFL7)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種Rattus norvegicus (Rat，大鼠)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 713 ¥ 1663 ¥ 2376 ¥ 5940 ¥ 23760
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P; Samples: Mouse Kidney Tissue; Primary Ab: 20μg/ml Rabbit Anti-Mouse EGFL7 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant EGFL7, Mouse.
-
Figure. Western Blot; Sample: Mouse Heart Tissue.
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對EGFL7的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別EGFL7。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPL643Mu01 | EGF樣域蛋白7(EGFL7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPL643Mu02 | EGF樣域蛋白7(EGFL7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAL643Mu02 | EGF樣域蛋白7(EGFL7)多克隆抗體 | WB; IHC; ICC; IP. |
| PAL643Mu01 | EGF樣域蛋白7(EGFL7)多克隆抗體 | WB; IHC; ICC; IP. |
| SEL643Mu | EGF樣域蛋白7(EGFL7)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LML643Mu | EGF樣域蛋白7(EGFL7)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Scientific Reports | Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab [PMC5443778] |
| Scientific Reports | Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab. [pubmed:28539619] |
| International Journal of Clinical and Experimental Pathology | EGF like domain multiple 7 regulates the migration and invasion of prostate cancer cells [ISSN:1936-2625] |
| Cancer Drug Resist | MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy [] |
留言咨詢
